Results 151 to 160 of about 4,480 (170)
Some of the next articles are maybe not open access.

A Validated UV Spectroscopic method for Quantification of Lidocaine HCl and Diltiazem HCl

A Simple and routinely used UV- Spectroscopic technique has been developed for estimating Lidocaine hydrochloride and Diltiazem hydrochloride in bulk and combined dosage form. The simultaneous estimation using first- order derivative analysis was 0.1 M HCl solvent, with scanning at wavelengths of 223 nm and 250 nm for quantifying lidocaine HCl and ...
Nirali Chaudhari   +4 more
openaire   +1 more source

In vivo performance of controlled release pellets of diltiazem HCl.

Pakistan journal of pharmaceutical sciences, 2006
The test formulation of controlled release diltiazem pellets was evaluated in vivo, in comparison with Herbesser SR. Six healthy volunteers participated in the study, conducted according to a randomized, two-way crossover study design. The preparations were compared using the pharmacokinetic parameters plasma concentration-time curve (AUC(0- infinity)),
, Nisarur-ur-Rahman   +2 more
openaire   +1 more source

FORMULATION AND IN VITRO EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF DILTIAZEM HCL

2023
The present study involves in the formulation and evaluation of Controlled release tablets of Diltiazem HCl (100mg). The objective of the present study was to formulate Diltiazem hcl Controlled release tablets by Direct compression method by using HPMC K 15M, HPC 2M and HEC 2M.
openaire   +1 more source

Sustained release of diltiazem HCl tableted after co-spray drying and physical mixing with PVAc and PVP

Drug Development and Industrial Pharmacy, 2015
In this work, aqueous diltiazem HCl and polyvinyl-pyrrolidone (PVP) solutions were mixed with Kollicoat SR 30D and spray dried to microparticles of different drug:excipient ratio and PVP content. Co-spray dried products and physical mixtures of drug, Kollidon SR and PVP were tableted.
Nizar, Al-Zoubi   +3 more
openaire   +2 more sources

Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients.

Clinical therapeutics, 1994
The safety and efficacy of an extended-release form of diltiazem HCl (diltiazem XR) in patients 55 years or older with mild-to-moderate essential hypertension were examined in a multi-center, double-blind, randomized, placebo-controlled, parallel-group study involving 350 patients with supine diastolic blood pressure (DBP) between 95 mm Hg and 114 mm ...
R, Fiddes   +7 more
openaire   +1 more source

Preparation of diltiazem HCl-modified release formulation using cation-exchange resin as a single excipient

Pharmaceutical Development and Technology
Modified released formulations of diltiazem were previously prepared using cation-exchange resins. However, multiple excipients were required to achieve the appropriate release rate. It was of interest to prepare a modified release dosage form of diltiazem using drug-resin complex alone.Adsorption experiments conducted using a rotating bottle apparatus.
Khouloud A, Alkhamis, Suhair S, Al-Nimry
openaire   +2 more sources

A New Extended‐Release Formulation of Diltiazem HCl for the Treatment of Mild‐to‐Moderate Hypertension

The Journal of Clinical Pharmacology, 1993
Calcium‐channel blockers are a safe and effective treatment modality and have been used extensively in the treatment of angina and hypertension. Dilacor™ XR capsules, a new extended‐release formulation of diltiazem, has been developed for the treatment of hypertension. Dilacor XR (Rhône‐Poulenc Rorer Pharmaceuticals Inc., Collegeville, PA) uses a novel
openaire   +2 more sources

The Gastrointestinal Transit and Systemic Absorption of Diltiazem HCL from a Modified Release Dosage Form

1993
The primary means of administration for the vast majority of therapeutic agents is via the oral route. Many of these oral dosage forms are designed to provide a rapid disintegration in the stomach, however, over the last 5–6 years there has been a growing trend within the pharmaceutical industry to develop complex pharmaceutical dosage forms designed ...
Donald L. Heald   +2 more
openaire   +1 more source

Delivery of diltiazem HCl

Membrane Technology, 1999
openaire   +1 more source

DilTIAZem HCl

Stephanie J. Phelps   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy